CRISPR Therapeutics AG announced the hiring of Andrew J. Silver as its Chief Financial Officer. This leadership change is the primary market-relevant event from the filing.
CRSP news
Latest 7 stories · newest Oct 19, 2026
CRSP
APP New CFO Andrew J. Silver Hired by CRISPR Therapeutics
CRSP
CRSP
CRSP
CRSP
CRSP
CRISPR Q2 Revenue Rose 151% YoY As FDA Approved CASGEVY for Children Aged 2+
CRISPR Therapeutics reported strong second-quarter financial results with CASGEVY revenue rising 151% year-over-year. The FDA recently expanded CASGEVY approval to children as young as 2 years old, while the company initiated new Phase 1 trials for in vivo candidates CTX340 and CTX460.
CRSP
CRISPR Therapeutics files updated articles of association
CRISPR Therapeutics AG filed amended articles of association as Exhibit 3.1 to an 8-K filing, updating corporate governance documents. The filing is administrative in nature with no material operational or financial impact disclosed.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same CRSP feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CRSP/newsSTART FREE